| Literature DB >> 25498860 |
Jeanelle Ariza1, Craig Steward2, Flora Rueckert2, Matt Widdison2, Robert Coffman2, Atiyeh Afjei2, Stephen C Noctor3, Randi Hagerman4, Paul Hagerman5, Verónica Martínez-Cerdeño6.
Abstract
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder associated with premutation alleles of the FMR1 gene that is characterized by progressive action tremor, gait ataxia, and cognitive decline. Recent studies of mitochondrial dysfunction in FXTAS have suggested that iron dysregulation may be one component of disease pathogenesis. We tested the hypothesis that iron dysregulation is part of the pathogenic process in FXTAS. We analyzed postmortem choroid plexus from FXTAS and control subjects, and found that in FXTAS iron accumulated in the stroma, transferrin levels were decreased in the epithelial cells, and transferrin receptor 1 distribution was shifted from the basolateral membrane (control) to a predominantly intracellular location (FXTAS). In addition, ferroportin and ceruloplasmin were markedly decreased within the epithelial cells. These alterations have implications not only for understanding the pathophysiology of FXTAS, but also for the development of new clinical treatments that may incorporate selective iron chelation.Entities:
Keywords: Autism; CGG repeat; Choroid plexus; FMR1; FXTAS; Fragile X; Iron; Neurodegeneration; Premutation
Mesh:
Substances:
Year: 2014 PMID: 25498860 PMCID: PMC4340768 DOI: 10.1016/j.brainres.2014.11.058
Source DB: PubMed Journal: Brain Res ISSN: 0006-8993 Impact factor: 3.252